ResMed stock jumped Friday after crushing sales estimates and wiping out worries that weight-loss drugs would squeeze sleep apnea device sales.
Integer Holdings' (ITGR) first-quarter results reflect robust Medical Sales, along with strength in all the product lines.
STOCKSTOWATCHTODAY BLOG Shares of ResMed were trading sharply higher after the medical devices company filed a quarterly report that left Wall Street cheering. On Friday, ResMed stock was rising 14% to $209.